tetano
Editor, Senior Moderator
Anal Bioanal Chem
. 2024 Mar 1.
doi: 10.1007/s00216-024-05205-z. Online ahead of print. Quantification of SARS-CoV-2 monoclonal IgG mass fraction by isotope dilution mass spectrometry
G Martos[SUP] 1 [/SUP], M Bedu[SUP] 2 [/SUP], R D Josephs[SUP] 2 [/SUP], S Westwood[SUP] 2 [/SUP], R I Wielgosz[SUP] 2 [/SUP]
Affiliations
The availability of serology assays to measure antibodies against the SARS coronavirus 2 (SARS-CoV-2) expanded rapidly during the Covid-19 pandemic. The interchangeable use of such assays to monitor disease progression and immune protection requires their standardization, for which suitably characterized monoclonal antibody materials can be useful. The methods, based on isotope dilution mass spectrometry, to value assign the mass fraction of such a material in solution within the context of an international interlaboratory comparison study (CCQM-P216) are described. The mass fraction in solution of a humanized IgG monoclonal antibody (mAb) against the SARS-CoV-2 Spike glycoprotein in the study sample has been value assigned through a combination of liquid chromatography, isotope dilution mass spectrometry (LC-ID-MS) methods and size exclusion chromatography with UV detection (SEC-UV). The former were developed for the quantification of amino acids and proteotypic peptides as surrogate analytes of the mAb while the latter was applied for the determination of the relative monomeric mass fraction. High-resolution mass spectrometry (hrMS) allowed the molecular weight evaluation and ruled out the presence of significant impurities. Method trueness was assessed using a subclass homologous IgG1 material value assigned by amino acid analysis. The assigned mass fraction of monomeric SARS-CoV-2 IgG in solution was 390 ± 16 mg/g. The associated expanded uncertainty originated mainly from acid hydrolysis variability and Trypsin/Lys-C digestion variability and efficiency.
Keywords: Amino acid analysis; Isotope dilution mass spectrometry; Measurement uncertainty; Monoclonal antibody; Reference material; SARS-CoV-2 antibodies.
. 2024 Mar 1.
doi: 10.1007/s00216-024-05205-z. Online ahead of print. Quantification of SARS-CoV-2 monoclonal IgG mass fraction by isotope dilution mass spectrometry
G Martos[SUP] 1 [/SUP], M Bedu[SUP] 2 [/SUP], R D Josephs[SUP] 2 [/SUP], S Westwood[SUP] 2 [/SUP], R I Wielgosz[SUP] 2 [/SUP]
Affiliations
- PMID: 38427100
- DOI: 10.1007/s00216-024-05205-z
The availability of serology assays to measure antibodies against the SARS coronavirus 2 (SARS-CoV-2) expanded rapidly during the Covid-19 pandemic. The interchangeable use of such assays to monitor disease progression and immune protection requires their standardization, for which suitably characterized monoclonal antibody materials can be useful. The methods, based on isotope dilution mass spectrometry, to value assign the mass fraction of such a material in solution within the context of an international interlaboratory comparison study (CCQM-P216) are described. The mass fraction in solution of a humanized IgG monoclonal antibody (mAb) against the SARS-CoV-2 Spike glycoprotein in the study sample has been value assigned through a combination of liquid chromatography, isotope dilution mass spectrometry (LC-ID-MS) methods and size exclusion chromatography with UV detection (SEC-UV). The former were developed for the quantification of amino acids and proteotypic peptides as surrogate analytes of the mAb while the latter was applied for the determination of the relative monomeric mass fraction. High-resolution mass spectrometry (hrMS) allowed the molecular weight evaluation and ruled out the presence of significant impurities. Method trueness was assessed using a subclass homologous IgG1 material value assigned by amino acid analysis. The assigned mass fraction of monomeric SARS-CoV-2 IgG in solution was 390 ± 16 mg/g. The associated expanded uncertainty originated mainly from acid hydrolysis variability and Trypsin/Lys-C digestion variability and efficiency.
Keywords: Amino acid analysis; Isotope dilution mass spectrometry; Measurement uncertainty; Monoclonal antibody; Reference material; SARS-CoV-2 antibodies.